Literature DB >> 7862860

Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents.

G Griebel1, J L Moreau, F Jenck, R Misslin, J R Martin.   

Abstract

This study investigated behavioural effects of very potent 5-HT reuptake inhibitors after acute treatment (cianopramine and citalopram), as well as after chronic treatment (cianopramine), in two behavioural models of anxiety: 1) the light/dark choice procedure in mice and 2) the elevated plus-maze test in rats. In addition, the responses of mice to novelty in a free exploration paradigm were assessed after acute administration of both drugs. A single injection of cianopramine or citalopram increased neophobic reactions in the free exploration test. Furthermore, these drugs increased the avoidance reaction to a brightly illuminated chamber in the light/dark choice procedure as well as to open arms in the elevated plus-maze test. In contrast, after chronic treatment (10 mg/kg IP, once daily for 21 days) of cianopramine, anxiogenic-like effects were no longer produced in the light/dark choice paradigm whereas in the elevated plus-maze test, anxiolytic-like effects appeared. These results shed more light on the 5-HT hypothesis of anxiety, insofar as the increased availability of 5-HT resulting here from reuptake inhibition seems to initially result in an increased emotional reactivity which, however, subsequently disappears during chronic treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862860     DOI: 10.1007/bf02245224

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety.

Authors:  S R Bodnoff; B Suranyi-Cadotte; R Quirion; M J Meaney
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  AMINE UPTAKE INHIBITORS: CRITERIA OF SELECTIVITY.

Authors:  L Maître; P Moser; P A Baumann; P C Waldmeier
Journal:  Acta Psychiatr Scand       Date:  1980-03       Impact factor: 6.392

3.  Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid?

Authors:  S Pellow
Journal:  Methods Find Exp Clin Pharmacol       Date:  1986-09

4.  Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses.

Authors:  B Saletu; J Grünberger
Journal:  J Clin Psychiatry       Date:  1985-03       Impact factor: 4.384

5.  Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat.

Authors:  D J Fontana; T J Carbary; R L Commissaris
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Interaction between effects of caffeine and lorazepam in performance tests and self-ratings.

Authors:  S E File; A J Bond; R G Lister
Journal:  J Clin Psychopharmacol       Date:  1982-04       Impact factor: 3.153

7.  Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

Authors:  R Invernizzi; S Belli; R Samanin
Journal:  Brain Res       Date:  1992-07-03       Impact factor: 3.252

8.  Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex.

Authors:  L Rägo; R A Kiivet; J Harro; M Pŏld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

9.  Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.

Authors:  S Pellow; A L Johnston; S E File
Journal:  J Pharm Pharmacol       Date:  1987-11       Impact factor: 3.765

10.  Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

Authors:  S Pellow; S E File
Journal:  Pharmacol Biochem Behav       Date:  1986-03       Impact factor: 3.533

View more
  36 in total

1.  Methoxetamine affects brain processing involved in emotional response in rats.

Authors:  M T Zanda; P Fadda; S Antinori; M Di Chio; W Fratta; C Chiamulera; L Fattore
Journal:  Br J Pharmacol       Date:  2017-08-19       Impact factor: 8.739

2.  Serotonin depletion eliminates sex differences with respect to context-conditioned immobility in rat.

Authors:  Robert Pettersson; Sven Melker Hagsäter; Elias Eriksson
Journal:  Psychopharmacology (Berl)       Date:  2016-02-24       Impact factor: 4.530

3.  The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands.

Authors:  G Griebel; D J Sanger; G Perrault
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

4.  The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine.

Authors:  Liliana P Montezinho; Silke Miller; Niels Plath; Nanna Hovelsø Jensen; Jens-Jakob Karlsson; Louise Witten; Arne Mørk
Journal:  Psychopharmacology (Berl)       Date:  2010-07-30       Impact factor: 4.530

5.  Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours.

Authors:  O J Onaolapo; T B Paul; A Y Onaolapo
Journal:  Metab Brain Dis       Date:  2017-05-15       Impact factor: 3.584

6.  Dorsal raphe neuroinflammation promotes dramatic behavioral stress dysregulation.

Authors:  Alexis R Howerton; Alison V Roland; Tracy L Bale
Journal:  J Neurosci       Date:  2014-05-21       Impact factor: 6.167

7.  Cerebral tryptophan hydroxylase activity, and 5-HT1A receptor, 5-HT2A receptor, and 5-HT transporter binding in grouped and isolated Roman RHA and RLA rats: relationships with behaviours in two models of anxiety.

Authors:  A Kulikov; N Castanon; P Mormède; F Chaouloff
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

8.  Differential effects of acute and repeated citalopram in mouse models of anxiety and depression.

Authors:  Cedric Mombereau; Tamar L Gur; Jennifer Onksen; Julie A Blendy
Journal:  Int J Neuropsychopharmacol       Date:  2009-12-14       Impact factor: 5.176

9.  The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram.

Authors:  Wei-Li Kuan; Jing-Wei Zhao; Roger A Barker
Journal:  Psychopharmacology (Berl)       Date:  2007-12-23       Impact factor: 4.530

Review 10.  The serotonergic system and anxiety.

Authors:  Joshua A Gordon; Rene Hen
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.